Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN).
Steve Kraus is a partner at Bessemer in the Cambridge office and a world-renowned healthcare investor. He is the author of Bessemer’s 10 Laws of Healthcare, Benchmarks for Growing Health tech Businesses, and is a co-host of A Healthy Dose podcast. Steve currently sits on the boards of Bright Health Group, Headspace Health, Groups, Qventus, AspenRx, HouseRx, Oshi Health, Folx Health, Mural Health, and Alcresta.
Prior to joining Bessemer, Steve worked for a growth-stage, private equity firm and as a management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.
He serves as an Observer at Beth Israel Deaconess Medical Center, an advisor to Boston Children’s Hospital and the Harvard Business School’s Center for Entrepreneurship, and on the investment committees of BCBS Massachusetts and Rock Health.
Steve graduated from summa cum laude from Yale University and earned his MBA from Harvard, where he was a Baker Scholar.
“Innovating in healthcare is really hard and really rewarding. Make sure you work with people who understand the industry deeply and work in it for all the right reasons.”